Skip to main content

Table 1

From: Pharmacokinetics of plasma lopinavir/ritonavir following the administration of 400/100, 200/150, and 200/50 mg twice daily in HIV-negative volunteers

PK parameter

400/100 BID

200/150 BID

200/50 BID

 

regimen 1

regimen 2

regimen 3

Lopinavir

   

AUC0-12 (ng.h/mL)

99599 (87180-113787)

73603 (65121-83191)

45146 (39251-51927)

Cmax (ng/mL)

11965 (10400-13766)

8939 (8047-9930)

6404 (5648-7262)

C12h (ng/mL)

5776 (4884-6831)

4293 (3603-5115)

1749 (1419-2156)

Ritonavir

   

AUC0-12 (ng.h/mL)

4664 (3808-5664)

10462 (8972-12200)

1625 (1390-1899)